
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
Keywords: apaziquone; urinary bladder neoplasms; drug therapy; administration; intravesical; AE; adverse event; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bla